Heritage Cannabis Holdings Corp C.CANN

Alternate Symbol(s): HERTF

Healthcare Cannabis

Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company.

CSE:CANN - Post by User

Heritage Cannabis Holdings Corp

Bullboard Posts

Comment by jvosh123on Nov 05, 2017 9:51am

146 Views

Post# 26908020

RE:RE:RE:thoughts about the possible 80 million shares that come free

Source of (potentially) 80m Shares

From the UMB website:

UMBRAL ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Vancouver, B.C., August 31, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) is pleased to announce that it has closed its previously announced (see press releases dated July 14, 2017 and August 24, 2017) non-brokered private of 43,700,000 units (the “Units”) at a price of $0.06 per Unit for gross proceeds of $2,622,000 (the “Offering”).

Each Unit consists of one common share in the capital of the Company (a “Share”) and one common share purchase warrant (a “Warrant”).Each Warrant will entitle the holder to purchase one additional Share until August 30, 2019 (subject to acceleration in certain circumstances) at a purchase price of $0.10 per Share.

In connection with the Offering, the Company has paid a cash commission in the aggregate amount of $91,900, being 8% of the aggregate proceeds raised from the sale of units to purchasers introduced by eligible finders.In addition, the Company has issued warrants (the “Finders’ Warrants”) to acquire a total of 1,531,653 Shares, being 8% of the number of Units sold under the Offering to purchasers introduced by such finders.Each Finders’ Warrant entitles the holder to purchase one Share at a price of $0.10 per Share until August 30, 2019 (subject to acceleration in certain circumstances).

Clint Sharples, Chairman of Umbral commented, “I am very proud of the efforts by Jag Bal and his team on this financing. The market is showing tremendous support and confidence in both Umbral and PhyeinMed as evidenced by this raise being significantly oversubscribed. We look forward to continuing to achieve the milestones in our plan over the coming months as we move closer to obtaining our goal of an ACMPR license"

All securities issued in connection with the Offering are subject to a statutory hold period expiring December 31, 2017 in accordance with applicable securities legislation.The proceeds from the Offering will be used to pay the balance of the purchase price for a Falkland, BC property (see press release dated July 13, 2017), completion of phase 1 of the build-out prior to an award of a license to cultivate, fund a work program on the Letourneau Property and for general working capital.

So by the first week of the new year this should be hitting the market. Without the warrents this is already 1/3 of current float.

I do think UMB is a winner, especially since it is connected to Canopy.

I dont know how accurate a comparison to MMJ would be, but they have 50 million pp shares hitting the market by Friday or Monday. I don't know if they will have to do the change of business as well.

GL